Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

clinicaltrials.gov/study/NCT00097045

Is a

‌

Clinical study

Clinical Study attributes

NCT Number

NCT000970450

Health Conditions in Trial

Hepatitis C

Trial Recruitment Size

900

Trial Sponsor

Intarcia Therapeutics

Clinical Trial Start Date

2004

Study Completion Date

2006

Clinical Trial Study Type

Interventional0

Interventional Trial Purpose

Treatment0

Interventional Trial Phase

Phase 20

Official Name

Phase 2 Study of Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C0

Last Updated

August 23, 2007

Allocation Type

Randomized0

Intervention Model

Parallel Assignment0

Masking Type

None (Open Label)0

Study summary

This study is designed to compare the safety, tolerability and antiviral effects of omega interferon administered alone to omega interferon administered with ribavirin in the treatment of subjects with chronic Hepatitis C virus (HCV) infection.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

Contents

Clinical Study attributes

Timeline

Further Resources

References

Find more entities like Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C